March 7-8, 2012
GDDIF 2012 - Global Discovery and Development Innovation Forum
Budapest, Hungary
March 12-17, 2012
American Society for Clinical Pharmacology and Therapeutics (ASCPT) Annual Meeting
National Harbor, Maryland
Rene Bruno, Ph.D., Managing Director, Pharsight Consulting Services Europe, will give an invited presentation as part of a session on "Should We Tolerate the Maximally Tolerated Dose for Targeted Anti-Cancer Agents?”
View Pharsight's Modeling and Simulation Framework to Support Oncology Drug Development Decisions